Dr Kaydo notes the full phase 3 data was published September 29, 2026. Retatrutide is still investigational and not approved by the FDA.
Recap by typeshit. Post by @drkaydo on Instagram.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Researchers reviewed records of nearly a million diabetic patients and found a 40% to 70% lower rate of first Alzheimer's diagnosis. Lead author Rong Xu says it's a link, not proof. Story dates from 2024.
South Korea's Ministry of Food and Drug Safety says it flagged hundreds of listings illegally selling or promoting weight-loss drugs.
Loading…